Detailed information for compound 2006879
Basic information
Technical information
- Name: Unnamed compound
- MW: 402.489 | Formula: C24H26N4O2
-
H donors: 3
H acceptors: 3
LogP: 2.76
Rotable bonds: 7
Rule of 5 violations (Lipinski): 1 - SMILES: N#C[C@H](Cc1ccc(cc1)c1cccc(c1)C(=O)N)NC(=O)[C@H]1NC2CCC1CC2
- InChi: 1S/C24H26N4O2/c25-14-21(28-24(30)22-17-8-10-20(27-22)11-9-17)12-15-4-6-16(7-5-15)18-2-1-3-19(13-18)23(26)29/h1-7,13,17,20-22,27H,8-12H2,(H2,26,29)(H,28,30)/t17?,20?,21-,22-/m0/s1
- InChiKey: DKVWNKVQQQEYMS-UIIOKCELSA-N
Network
Hover on a compound node to display the structore
Synonyms
No synonyms found for this compound
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Homo sapiens | cathepsin C | Starlite/ChEMBL | No references |
| Homo sapiens | cathepsin K | Starlite/ChEMBL | No references |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
| Species | Potential target | Known druggable target | Length | Alignment span | Identity |
|---|---|---|---|---|---|
| Plasmodium falciparum | cysteine proteinase falcipain 1 | cathepsin K | 329 aa | 349 aa | 33.2 % |
| Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | cathepsin C | 141 aa | 152 aa | 22.4 % |
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Brugia malayi | Cathepsin L-like cysteine proteinase | 0.0018 | 0.0188 | 0.3182 |
| Schistosoma mansoni | cathepsin F (C01 family) | 0.0018 | 0.0188 | 0.0188 |
| Brugia malayi | Cathepsin L-like precursor | 0.0027 | 0.0591 | 1 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Echinococcus granulosus | cathepsin l1 | 0.0018 | 0.0188 | 0.3182 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Loa Loa (eye worm) | Papain cysteine protease/cathepsin propeptide inhibitor-containing protein | 0.0027 | 0.0591 | 1 |
| Loa Loa (eye worm) | ctsf protein | 0.0027 | 0.0591 | 1 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L or K-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Brugia malayi | Cathepsin L-like precursor | 0.0018 | 0.0188 | 0.3182 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Brugia malayi | Cathepsin L-like precursor | 0.0027 | 0.0591 | 1 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trypanosoma cruzi | cysteine peptidase, clan CA, family C1, cathepsin L-like, putative | 0.0018 | 0.0188 | 0.3182 |
| Plasmodium falciparum | cysteine proteinase falcipain 2b | 0.0027 | 0.0591 | 0.0591 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Trypanosoma cruzi | cysteine peptidase, putative | 0.0027 | 0.0591 | 1 |
| Brugia malayi | Cathepsin L-like precursor | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0148 | 0.6053 | 1 |
| Onchocerca volvulus | Cathepsin L homolog | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.0235 | 1 | 1 |
| Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.0235 | 1 | 1 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Brugia malayi | Cathepsin L-like precursor | 0.0027 | 0.0591 | 1 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.0235 | 1 | 1 |
| Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.0235 | 1 | 1 |
| Plasmodium falciparum | cysteine proteinase falcipain 3 | 0.0027 | 0.0591 | 0.0591 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trypanosoma cruzi | cysteine peptidase, putative | 0.0027 | 0.0591 | 1 |
| Loa Loa (eye worm) | cysteine protease | 0.0027 | 0.0591 | 1 |
| Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | 0.0092 | 0.3544 | 0.3544 |
| Echinococcus multilocularis | cathepsin L cysteine protease | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L or K-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Plasmodium falciparum | cysteine proteinase falcipain 2a | 0.0027 | 0.0591 | 0.0591 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trypanosoma cruzi | cruzipain precursor, putative | 0.0027 | 0.0591 | 1 |
| Echinococcus multilocularis | cathepsin L cysteine protease | 0.0027 | 0.0591 | 1 |
| Loa Loa (eye worm) | papain family cysteine protease containing protein | 0.0027 | 0.0591 | 1 |
| Brugia malayi | cathepsin L-like precursor | 0.0018 | 0.0188 | 0.3182 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0018 | 0.0188 | 0.0311 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Toxoplasma gondii | cathepsin CPC1 | 0.0235 | 1 | 1 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Onchocerca volvulus | Cathepsin F homolog | 0.0027 | 0.0591 | 1 |
| Loa Loa (eye worm) | fibroinase | 0.0027 | 0.0591 | 1 |
| Plasmodium falciparum | dipeptidyl aminopeptidase 3 | 0.0092 | 0.3544 | 0.3544 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Brugia malayi | Cathepsin L-like precursor | 0.0027 | 0.0591 | 1 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Brugia malayi | Papain family cysteine protease containing protein | 0.0027 | 0.0591 | 1 |
| Echinococcus multilocularis | cysteine protease | 0.0027 | 0.0591 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0591 | 1 |
| Trypanosoma cruzi | cysteine peptidase, putative | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Toxoplasma gondii | cathepsin CPC2 | 0.0092 | 0.3544 | 0.3139 |
| Schistosoma mansoni | cathepsin F (C01 family) | 0.0027 | 0.0591 | 0.0591 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0018 | 0.0188 | 0.0311 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Plasmodium vivax | vivapain-2 | 0.0027 | 0.0591 | 0.0591 |
| Echinococcus granulosus | cathepsin l1 | 0.0027 | 0.0591 | 1 |
| Schistosoma mansoni | cathepsin F (C01 family) | 0.0027 | 0.0591 | 0.0591 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Entamoeba histolytica | cysteine proteinase, putative | 0.0018 | 0.0188 | 0.3182 |
| Leishmania major | cysteine peptidase A (CPA) | 0.0027 | 0.0591 | 0.5 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Entamoeba histolytica | cysteine proteinase, putative | 0.0027 | 0.0591 | 1 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Brugia malayi | Cathepsin L-like precursor | 0.0027 | 0.0591 | 1 |
| Onchocerca volvulus | Cathepsin L homolog | 0.0027 | 0.0591 | 1 |
| Plasmodium vivax | vivapain-2 | 0.0027 | 0.0591 | 0.0591 |
| Brugia malayi | Cathepsin L-like precursor | 0.0018 | 0.0188 | 0.3182 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.0235 | 1 | 1 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Entamoeba histolytica | cysteine proteinase, putative | 0.0027 | 0.0591 | 1 |
| Echinococcus granulosus | cathepsin L cysteine proteinase | 0.0027 | 0.0591 | 1 |
| Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Echinococcus granulosus | cathepsin l cysteine peptidase | 0.0027 | 0.0591 | 1 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Entamoeba histolytica | cysteine protease, putative | 0.0027 | 0.0591 | 1 |
| Toxoplasma gondii | preprocathepsin c precursor, putative | 0.0235 | 1 | 1 |
| Echinococcus multilocularis | cysteine protease | 0.0027 | 0.0591 | 1 |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Trypanosoma cruzi | cysteine peptidase, putative | 0.0027 | 0.0591 | 1 |
| Leishmania major | cathepsin L-like protease | 0.0027 | 0.0591 | 0.5 |
| Onchocerca volvulus | 0.0027 | 0.0591 | 1 | |
| Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
| Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0027 | 0.0591 | 0.0976 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (binding) | = 130.7 nM | BindingDB_Patents: Inhibition Assay. The following buffers were used: MES buffer: 25 mM MES, 50 mM NaCl, 5 mM DTT, adjusted to pH 6.0, containing 0.1% BSA; TAGZyme Buffer: 20 mM NaH2P04, 150 mM NaCl adjusted to pH 6.0 with HC1Assay conditions: The recombinant human DPPI was diluted in TAGZyme buffer to 1 U/ml (38.1 ug/ml, respectively), and then activated by mixing in a 1 :2 ratio with a Cysteamine aqueous solution ( 2mM) and incubating for 5 min at room temperature.Five uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uM of DPPI in MES buffer (final concentration 0.0125 ng/uL) and incubated for 10 min. Then, 5 uL of substrate in MES buffer (final concentration 50 uM) were added. The microtiter plates were then incubated at room temperature for 30 min. Then, the reaction was stopped by adding 10 uL of Gly-Phe-DMK in MES-buffer (final concentration 1 uM). | ChEMBL. | No reference |
| IC50 (binding) | = 130.7 nM | BindingDB_Patents: Inhibition Assay. The recombinant human DPPI was diluted in TAGZyme buffer to 1 U/ml (38.1 ug/ml, respectively), and then activated by mixing in a 1:2 ratio with a Cysteamine aqueous solution (2 mM) and incubating for 5 min at room temperature.Five uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of DPPI in MES buffer (final concentration 0.0125 ng/uL) and incubated for 10 min. Then, 5 uL of substrate in MES buffer (final concentration 50 uM) were added. The microtiter plates were then incubated at room temperature for 30 min. Then, the reaction was stopped by adding 10 uL of Gly-Phe-DMK in MES-buffer (final concentration 1 uM). The fluorescence in the wells was determined using a Molecular Devices SpectraMax M5 Fluorescence Reader (Ex 360 nm, Em 460 nm) or an Envision Fluorescence Reader (Ex 355 nm, Em 460 nm). | ChEMBL. | No reference |
| IC50 (binding) | = 130.7 nM | BindingDB_Patents: Inhibition Assay. The recombinant human DPPI was diluted in TAGZyme buffer to 1 U/ml (38.1 ug/ml, respectively), and then activated by mixing in a 1:2 ratio with a Cysteamine aqueous solution (2 mM) and incubating for 5 min at room temperature.Five uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of DPPI in MES buffer (final concentration 0.0125 ng/uL) and incubated for 10 min. Then, 5 uL of substrate in MES buffer (final concentration 50 uM) were added. The microtiter plates were then incubated at room temperature for 30 min. Then, the reaction was stopped by adding 10 uL of Gly-Phe-DMK in MES-buffer (final concentration 1 uM). The fluorescence in the wells was determined using a Molecular Devices SpectraMax M5 Fluorescence Reader (Ex 360 nm, Em 460 nm) or an Envision Fluorescence Reader (Ex 355 nm, Em 460 nm). | ChEMBL. | No reference |
| IC50 (binding) | = 130.7 nM | BindingDB_Patents: Inhibition Assay. The following buffers were used: MES buffer: 25 mM MES, 50 mM NaCl, 5 mM DTT, adjusted to pH 6.0, containing 0.1% BSA; TAGZyme Buffer: 20 mM NaH2P04, 150 mM NaCl adjusted to pH 6.0 with HC1Assay conditions: The recombinant human DPPI was diluted in TAGZyme buffer to 1 U/ml (38.1 ug/ml, respectively), and then activated by mixing in a 1 :2 ratio with a Cysteamine aqueous solution ( 2mM) and incubating for 5 min at room temperature.Five uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uM of DPPI in MES buffer (final concentration 0.0125 ng/uL) and incubated for 10 min. Then, 5 uL of substrate in MES buffer (final concentration 50 uM) were added. The microtiter plates were then incubated at room temperature for 30 min. Then, the reaction was stopped by adding 10 uL of Gly-Phe-DMK in MES-buffer (final concentration 1 uM). | ChEMBL. | No reference |
| IC50 (binding) | = 9700 nM | BindingDB_Patents: Inhibition Assay. The following buffers were used: Activation buffer: 32.5 mM sodium acetate, adjusted to pH 3.5 with HCl; Assay buffer: 150 mM sodium acetate, 4mM EDTA, 20 mM L-Cysteine, adjusted to pH 5.5 with HCl,Assay conditions: To activate the proenzyme, 5 uLprocathepsin K were mixed with 1 ul activation buffer, and incubated at room temperature for 30 min. 5 uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of Cathepsin K in assay buffer (final concentration 2 ng/uL) and incubated for 10 min. Then 5 uL of substrate in assay buffer (final concentration 12.5 uM) were added. The plates were then incubated at room temperature for 60min. Then, the reaction was stopped by adding 10 uL of E64 in assay buffer (final concentration 1 uM). The fluorescence in the wells was determined using a Molecular Devices SpectraMax M5 Fluorescence Reader. | ChEMBL. | No reference |
| IC50 (binding) | = 9700 nM | BindingDB_Patents: Inhibition Assay. To activate the proenzyme, 5 ul procathepsin K were mixed with 1 ul activation buffer, and incubated at room temperature for 30 min.5 uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of Cathepsin K in assay buffer (final concentration 2 ng/uL) and incubated for 10 min. Then 5 uL of substrate in assay buffer (final concentration 12.5 uM) were added. The plates were then incubated at room temperature for 60 min. Then, the reaction was stopped by adding 10 uL of E64 in assay buffer (final concentration 1 uM). The fluorescence in the wells was determined using a Molecular Devices SpectraMax M5 Fluorescence Reader (Ex 360 nm, Em 460 nm).Each assay microtiter plate contains wells with vehicle controls (1% DMSO in bidest) as reference for non-inhibited enzyme activity (100% Ctl; high values) and wells with inhibitor (E64 in bidest+1% DMSO. | ChEMBL. | No reference |
| IC50 (binding) | = 9700 nM | BindingDB_Patents: Inhibition Assay. To activate the proenzyme, 5 ul procathepsin K were mixed with 1 ul activation buffer, and incubated at room temperature for 30 min.5 uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of Cathepsin K in assay buffer (final concentration 2 ng/uL) and incubated for 10 min. Then 5 uL of substrate in assay buffer (final concentration 12.5 uM) were added. The plates were then incubated at room temperature for 60 min. Then, the reaction was stopped by adding 10 uL of E64 in assay buffer (final concentration 1 uM). The fluorescence in the wells was determined using a Molecular Devices SpectraMax M5 Fluorescence Reader (Ex 360 nm, Em 460 nm).Each assay microtiter plate contains wells with vehicle controls (1% DMSO in bidest) as reference for non-inhibited enzyme activity (100% Ctl; high values) and wells with inhibitor (E64 in bidest+1% DMSO. | ChEMBL. | No reference |
| IC50 (binding) | = 9700 nM | BindingDB_Patents: Inhibition Assay. The following buffers were used: Activation buffer: 32.5 mM sodium acetate, adjusted to pH 3.5 with HCl; Assay buffer: 150 mM sodium acetate, 4mM EDTA, 20 mM L-Cysteine, adjusted to pH 5.5 with HCl,Assay conditions: To activate the proenzyme, 5 uLprocathepsin K were mixed with 1 ul activation buffer, and incubated at room temperature for 30 min. 5 uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of Cathepsin K in assay buffer (final concentration 2 ng/uL) and incubated for 10 min. Then 5 uL of substrate in assay buffer (final concentration 12.5 uM) were added. The plates were then incubated at room temperature for 60min. Then, the reaction was stopped by adding 10 uL of E64 in assay buffer (final concentration 1 uM). The fluorescence in the wells was determined using a Molecular Devices SpectraMax M5 Fluorescence Reader. | ChEMBL. | No reference |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL3695345
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.